Trexquant Investment LP cut its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 57.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 279,883 shares of the company's stock after selling 378,095 shares during the period. Trexquant Investment LP owned approximately 0.11% of Oscar Health worth $3,762,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. KBC Group NV boosted its stake in Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after purchasing an additional 2,555 shares during the period. ORG Wealth Partners LLC purchased a new stake in shares of Oscar Health in the fourth quarter valued at $100,000. Alberta Investment Management Corp acquired a new stake in shares of Oscar Health in the fourth quarter worth $138,000. Virtu Financial LLC purchased a new position in shares of Oscar Health during the fourth quarter valued at $140,000. Finally, Potentia Wealth acquired a new position in Oscar Health during the fourth quarter valued at $141,000. 75.70% of the stock is owned by hedge funds and other institutional investors.
Oscar Health Stock Up 2.8 %
Shares of NYSE:OSCR traded up $0.34 during midday trading on Friday, hitting $12.59. 3,640,827 shares of the stock were exchanged, compared to its average volume of 3,868,096. The company has a market capitalization of $3.15 billion, a PE ratio of -629.19 and a beta of 1.75. Oscar Health, Inc. has a 52-week low of $11.47 and a 52-week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The business's fifty day simple moving average is $14.02 and its two-hundred day simple moving average is $15.35.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Separately, Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $20.21.
Read Our Latest Research Report on OSCR
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
